SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001016169-09-000004
Filing Date
2009-03-25
Accepted
2009-03-25 09:48:38
Documents
11
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 edgar10k.htm 10-K 2380108
2 GRAPHIC img1.jpg GRAPHIC 21168
3 GRAPHIC img2.jpg GRAPHIC 22444
4 GRAPHIC img3.gif GRAPHIC 6122
5 GRAPHIC img3.jpg GRAPHIC 8394
6 ex211.htm EX-21 9151
7 ex231.htm EX-23 4662
8 PAUL ex311.htm EX-31 21474
9 BOB ex312.htm EX-31 21480
10 CEO ex321ceo.htm EX-32 9064
11 CFO ex322.htm EX-32 9068
  Complete submission text file 0001016169-09-000004.txt   2537344
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 10-K | Act: 34 | File No.: 001-32302 | Film No.: 09702949
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10